| # | Drug | Count |
|---|---|---|
| 0 | LISDEXAMFETAMINE | 3 |
| 1 | LISDEXAMFETAMINE DIMESYLATE | 3 |
| 2 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 3 |
| 3 | OMALIZUMAB | 3 |
| 4 | OMEPRAZOLE | 3 |
| 5 | OMEPRAZOLE MAGNESIUM | 3 |
| 6 | 0XYGEN | 2 |
| 7 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 2 |
| 8 | DICLOFENAC | 2 |
| 9 | DICLOFENAC SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 2 | 0.0057 |
| 1 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 2 | 0.0054 |
| 2 | VIMSELTINIB | 1 | 0.0018 |
| 3 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 3 | 0.0006 |
| 4 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 5 | BEMPEDOIC ACID | 1 | 0.0004 |
| 6 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 7 | LISDEXAMFETAMINE DIMESYLATE | 3 | 0.0001 |
| 8 | RASAGILINE MESYLATE | 1 | 0.0001 |
| 9 | DICLOFENAC SODIUM 1% | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 3 | Anti-IgE [EPC] | 3 | 0.0000 |
| 4 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |